Do Prescription Drug Advertisements Educate the Public? The Consumer Answers

Debora A Paterniti, Robert A Bell, Richard L Kravitz, Henry N. Young

Research output: Contribution to journalArticle

Abstract

Increasing reliance upon direct-to-consumer advertising (DTCA) to promote prescription medications has intensified debate about advertising effects on patients and the educational merits of the advertisements. This research investigates, from the consumers’ point of view, the capacity of drug advertising to educate. We conducted focus groups to examine consumers’ drug information needs as well as their perceptions of DTCA's usefulness and quality. Information needs reported by participants included drug purpose, risks, benefits, cost information, and treatment options. Participants felt DTCA raised awareness but provided limited information about the benefits, harms, and uses of specific drugs. Perceived limitations of DTC advertisements include garbled messages, poor formats, and sparse details about clinical research, costs, and comparative therapies. Findings indicate drug advertisements may not serve to educate consumers in the way DTCA proponents contend. The educational value of DTCA could be improved by requiring advertisements to provide specific drug and medical condition information in a format easily understood by lay audiences.

Original languageEnglish (US)
Pages (from-to)25-33
Number of pages9
JournalTherapeutic Innovation and Regulatory Science
Volume39
Issue number1
DOIs
StatePublished - 2005

Fingerprint

Prescription Drugs
Pharmaceutical Preparations
Focus Groups
Research
Cost-Benefit Analysis
Prescriptions
Costs and Cost Analysis
Direct-to-Consumer Advertising
Therapeutics

Keywords

  • Drug Advertising
  • Educational Value
  • Opinions

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
  • Public Health, Environmental and Occupational Health
  • Pharmacology (medical)

Cite this

Do Prescription Drug Advertisements Educate the Public? The Consumer Answers. / Paterniti, Debora A; Bell, Robert A; Kravitz, Richard L; Young, Henry N.

In: Therapeutic Innovation and Regulatory Science, Vol. 39, No. 1, 2005, p. 25-33.

Research output: Contribution to journalArticle

@article{ef6c6a9090ae4f98b8abb3472b2cb7c1,
title = "Do Prescription Drug Advertisements Educate the Public? The Consumer Answers",
abstract = "Increasing reliance upon direct-to-consumer advertising (DTCA) to promote prescription medications has intensified debate about advertising effects on patients and the educational merits of the advertisements. This research investigates, from the consumers’ point of view, the capacity of drug advertising to educate. We conducted focus groups to examine consumers’ drug information needs as well as their perceptions of DTCA's usefulness and quality. Information needs reported by participants included drug purpose, risks, benefits, cost information, and treatment options. Participants felt DTCA raised awareness but provided limited information about the benefits, harms, and uses of specific drugs. Perceived limitations of DTC advertisements include garbled messages, poor formats, and sparse details about clinical research, costs, and comparative therapies. Findings indicate drug advertisements may not serve to educate consumers in the way DTCA proponents contend. The educational value of DTCA could be improved by requiring advertisements to provide specific drug and medical condition information in a format easily understood by lay audiences.",
keywords = "Drug Advertising, Educational Value, Opinions",
author = "Paterniti, {Debora A} and Bell, {Robert A} and Kravitz, {Richard L} and Young, {Henry N.}",
year = "2005",
doi = "10.1177/009286150503900104",
language = "English (US)",
volume = "39",
pages = "25--33",
journal = "Therapeutic Innovation and Regulatory Science",
issn = "2168-4790",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - Do Prescription Drug Advertisements Educate the Public? The Consumer Answers

AU - Paterniti, Debora A

AU - Bell, Robert A

AU - Kravitz, Richard L

AU - Young, Henry N.

PY - 2005

Y1 - 2005

N2 - Increasing reliance upon direct-to-consumer advertising (DTCA) to promote prescription medications has intensified debate about advertising effects on patients and the educational merits of the advertisements. This research investigates, from the consumers’ point of view, the capacity of drug advertising to educate. We conducted focus groups to examine consumers’ drug information needs as well as their perceptions of DTCA's usefulness and quality. Information needs reported by participants included drug purpose, risks, benefits, cost information, and treatment options. Participants felt DTCA raised awareness but provided limited information about the benefits, harms, and uses of specific drugs. Perceived limitations of DTC advertisements include garbled messages, poor formats, and sparse details about clinical research, costs, and comparative therapies. Findings indicate drug advertisements may not serve to educate consumers in the way DTCA proponents contend. The educational value of DTCA could be improved by requiring advertisements to provide specific drug and medical condition information in a format easily understood by lay audiences.

AB - Increasing reliance upon direct-to-consumer advertising (DTCA) to promote prescription medications has intensified debate about advertising effects on patients and the educational merits of the advertisements. This research investigates, from the consumers’ point of view, the capacity of drug advertising to educate. We conducted focus groups to examine consumers’ drug information needs as well as their perceptions of DTCA's usefulness and quality. Information needs reported by participants included drug purpose, risks, benefits, cost information, and treatment options. Participants felt DTCA raised awareness but provided limited information about the benefits, harms, and uses of specific drugs. Perceived limitations of DTC advertisements include garbled messages, poor formats, and sparse details about clinical research, costs, and comparative therapies. Findings indicate drug advertisements may not serve to educate consumers in the way DTCA proponents contend. The educational value of DTCA could be improved by requiring advertisements to provide specific drug and medical condition information in a format easily understood by lay audiences.

KW - Drug Advertising

KW - Educational Value

KW - Opinions

UR - http://www.scopus.com/inward/record.url?scp=84996154064&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84996154064&partnerID=8YFLogxK

U2 - 10.1177/009286150503900104

DO - 10.1177/009286150503900104

M3 - Article

VL - 39

SP - 25

EP - 33

JO - Therapeutic Innovation and Regulatory Science

JF - Therapeutic Innovation and Regulatory Science

SN - 2168-4790

IS - 1

ER -